Pontos | Posição | |
---|---|---|
CEF.UP+NIPE (average of all rankings) (2012) | 14.75 | 311/501 |
Australian RC (2010) | 50.0 | 324/479 |
CNRS (2008) | 40.0 | 170/336 |
Ideas discounted recursive impact factor (2012) | 0.14 | 365/396 |
ISI, JCR SSE, Impact Factor (2010) | 23.61 | 72/388 |
Schneider and Ursprung (2008) | 20.0 | 204/278 |
Source Normalized Impact per Paper (SNIP) (2011) | 8.51 | 303/476 |
Article Influence Score (2021) | 1.12 | 167/409 |
Article Influence Score (2019) | 0.84 | 185/428 |
Impact Factor (2021) | 5.27 | 62/409 |
Impact Factor (2019) | 2.37 | 117/440 |
Impact Factor (5 year) (2021) | 4.13 | 116/409 |
Impact Factor (5 year) (2019) | 2.53 | 149/428 |
SJR - Scimago (2021) | 0.87 | 231/558 |
SJR - Scimago (2019) | 0.96 | 214/549 |
Count (2021) | 1.0 | 155/652 |
HIT-6 and EQ-5D-5L in Patients with Migraine: Assessment of Common Latent Constructs and Development of a Mapping Algorithm
Ana Sofia Oliveira Goncalves,
Dimitra Panteli,
Lars Neeb,
Tobias Kurth,
Annette Aigner
vol. 23, 2022, p. 47-57.
Pharmaceutical Pricing Dynamics in an Internal Reference Pricing System: Evidence from Changing Drugs' Reimbursements
Eduardo Costa,
Carolina Santos
vol. 23, 2022, p. 1497-1518.
Survival Analysis of Cancer Patients in Portugal following the Reference Centre Model Implementation
Manuel Melo Mateus,
Margarida Catalão Lopes,
Rui Portugal
vol. , 2022, p. .
The Impact of Cancellations in Waiting Times Analysis: Evidence from Scheduled Surgeries in the Portuguese NHS
Joana Cima,
Alvaro Almeida
vol. 23, 2022, p. 95-104.
Does Waiting Time Decrease or Increase Operational Costs in Short and Long-Term? Evidence from Portuguese Public Hospitals
André Madeira,
Victor Moutinho,
Jose A. Fuinhas
vol. 22, 2021, p. 1195-1216.
Does waiting times decrease or increase operational costs in short and long-term? Evidence from Portuguese public hospitals.
André Madeira,
Victor Moutinho,
Jose A. Fuinhas
vol. 22, 2021, p. 1195-1216.
Multi-layer Health Insurance Coverage, Medical Services Use and Health in a Universal National Health System, the Case of Portugal
Aida Isabel Tavares,
Ines Marques
vol. 22, 2021, p. 141-153.
Advanced Therapy Medicinal Products: Value Judgement and Ethical Evaluation in Health Technology Assessment
Elisabete Goncalves
vol. 21, 2020, p. 311-320.
Multi-criteria Decision Analysis for Health Technology Assessment: Addressing Methodological Challenges to Improve the State of the Art
Monica Duarte Oliveira,
Ines Mataloto,
Panos Kanavos
vol. 20, 2019, p. 891-918.
Junior Doctors' Medical Specialty and Practice Location Choice: Simulating Policies to Overcome Regional Inequalities
Pedro Ramos,
Hélio Alves,
Paulo Guimarães,
Maria A. Ferreira
vol. 18, 2017, p. 1013-1030.
The Place of DPP-4 Inhibitors in the Treatment Algorithm of Diabetes Type 2: A Systematic Review of Cost-Effectiveness Studies
Alexandre Baptista,
Inês Teixeira,
Sonia Romano,
Antonio Vaz Carneiro,
Julian Perelman
vol. 18, 2017, p. 937-965.
The Economic Impact of Chronic Pain: A Nationwide Population-Based Cost-of-Illness Study in Portugal
Luis Filipe Azevedo,
Altamiro Costa-Pereira,
Liliane Mendonca,
Claudia Camila Dias,
José M. Castro-Lopes
vol. 17, 2016, p. 87-98.
Demand Uncertainty and Hospital Costs: An Application to Portuguese Public Hospitals
Alvaro Almeida,
Joana Ferreira Cima
vol. 16, 2015, p. 35-45.
Did the Corporatization of Portuguese Hospitals Significantly Change Their Productivity?
Diogo Ferreira,
Rui Cunha Marques
vol. 16, 2015, p. 289-303.
SF-6D Portuguese Population Norms
Pedro Augusto Ferreira,
Lara N Ferreira,
Luis Nobre Pereira
vol. 16, 2015, p. 235-241.
Cost-Effectiveness of Lung Transplantation and Its Evolution: The Portuguese Case
Luís Mendonça,
Julian Perelman,
Vanessa Rodrigues,
José Fragata
vol. 15, 2014, p. 767-772.
Cost Effects of Hospital Mergers in Portugal
Helda Azevedo,
Céu Mateus
vol. 15, 2014, p. 999-1010.
Does Health Promote Economic Growth? Portuguese Case Study: From Dictatorship to Full Democracy
Sónia Maria Aniceto Morgado
vol. 15, 2014, p. 591-598.
Analysis of HIV/AIDS DRG in Portugal: A Hierarchical Finite Mixture Model
Sara Simões Dias,
Valeska Andreozzi,
Rosário O. Martins
vol. 14, 2013, p. 715-723.
Patients` Access to Biologics in Rheumatoid Arthritis: A Comparison between Portugal and Other European Countries
Pedro A. Laires,
F. Exposto,
Rui Mesquita,
Ana P. Martins,
Luís Cunha-Miranda,
João Eurico Fonseca
vol. 14, 2013, p. 875-885.
Colorectal Cancer in Portugal
Carlos Gouveia Pinto,
Ana Teresa Paquete,
Irene Pissarra
vol. 10, 2010, p. 65-73.
Geographic Distribution of Physicians in Portugal
Isabel Correia,
Paula Veiga
vol. 11, 2010, p. 383-393.
The Challenge of Corporatisation: The Experience of Portuguese Public Hospitals
Guilhermina Rego,
Rui Nunes,
José Costa
vol. 11, 2010, p. 367-381.
Contractual Design and PPPs for Hospitals: Lessons for the Portuguese Model
Pedro Pita Barros,
Xavier Martinez-Giralt
vol. 10, 2009, p. 437-453.
Substance Abuse Treatment, What Do We Know? An Economist´s Perspective
Matilde Machado
vol. 6, 2005, p. 53-64.
Pricing and Reimbursement of Pharmaceuticals in Portugal
Carlos Gouveia Pinto,
Inês Teixeira
vol. 3, 2002, p. 267-270.